|
Tropical Journal of Pharmaceutical Research
Pharmacotherapy Group, Faculty of Pharmacy, University of Benin, Benin City, Nigeria
ISSN: 1596-5996 EISSN: 1596-5996
Vol. 13, No. 9, 2014, pp. 1555-1560
|
Bioline Code: pr14214
Full paper language: English
Document type: Case Report
Document available free of charge
|
|
Tropical Journal of Pharmaceutical Research, Vol. 13, No. 9, 2014, pp. 1555-1560
en |
A Report of Six Clinical Cases of Lowered Blood Cholesterol Profile Associated with Supplementation with Polypeptide K (Diabegard®), a Polypeptide Isolated from the Seeds of Momordica charantia Linn
Sirn, Yong Yean; Lok, Lee Cheng; Ahmad, Zuraini & Hakim, Muhammad Nazrul
Abstract
Purpose: To assess six patients with Diabegard® supplementation with reference to cholesterol
profiles. Methods: We report the clinical courses of six individuals taking Diabegard® supplementation at 60 and
120 mg/day for 8 weeks. Results: Patients had a maximum of 52.13 % reduction in low-density lipoprotein (LDL) cholesterol,
47.67 % reduction in triglycerides and 35.78 % reduction in total cholesterol (TC) within 8 weeks of
Diabegard® supplementation. Interestingly, high-density lipoprotein (HDL) cholesterol increased by
approximately 23.29 %. Patients also had reduced readings for C-reactive protein (CRP) and
homocysteine (with maximum reduction of 81.58 % and 57.41 % respectively). In some patients, these
parameters were elevated prior to supplementation. Conclusion: These results suggest that supplementation of Diabegard® will improve patients’
cholesterol profile by reduction of LDL and TC. Patients also expressed lower CRP and homocysteine
indicating reduced inflammation and reduction of cardiovascular diseases (CVD) risk. However, patients
taking this supplementation are advised to seek medical consultation in monitoring their cholesterol and
other biochemical profile levels.
Keywords
Hypocholesterolemia; Diabegard®; Momordica charantia; C-reactive protein; Inflammation; Cardiovascular disease
|
|
© Copyright 2014 - Tropical Journal of Pharmaceutical Research Alternative site location: http://www.tjpr.org
|
|